| ADHD | attention deficit hyperactivity disorder |
| AMP | amphetamine |
| ASC | amphetamine salt combination |
| ASMs | antiseizure medications |
| BECTS | benign epilepsy with centrotemporal spikes |
| BRE | benign rolandic epilepsy |
| CAE | childhood absence epilepsy |
| CWE | children with epilepsy |
| DAS | dextroamphetamine sulfate |
| DAT | dopamine transporters |
| D-MPH | dexmethylphenidate hydrochloride |
| DNRI | dopamine and norepinephrine reuptake inhibitor |
| DSM | Diagnostic and Statistical Manual of Mental Disorders |
| EEG | electroencephalogram |
| FDA | Food and Drug Administration |
| FLE | frontal lobe epilepsy |
| GABA | γ-aminobutyric acid |
| GWAS | genome-wide association studies |
| ILAE | International League Against Epilepsy |
| IQ | intelligence quotient |
| LDX | lisdexamfetamine dimesylate |
| MAH | methamphetamine hydrochloride |
| MECP2 | methyl-CpG binding protein 2 |
| MEF2C | myocyte enhancer factor 2 |
| MPH | methylphenidate |
| MPHH | methylphenidate hydrochloride |
| NET | norepineph- rine transporter |
| SBG | Scutellaria baicalensis Georgi |
| SDX | Serdexmethylphenidate |
| SEEG | stereo electroencephalogram |
| SERT | serotonin transporter |
| SNP | single nucleotide polymorphism |
| VMAT2 | vesicular monoamine transporter 2 |
| VTX | Vortioxetine |